PCI Suite: Road Map Fusion Imaging in Coronary Diagnostics and Therapy

Last updated: February 6, 2020
Sponsor: Heinrich-Heine University, Duesseldorf
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT03074721
16-022
  • Ages > 18
  • All Genders

Study Summary

The PCI Suite is developed by Philips Medical Systems, a Philips Healthcare company. The proposed PCI Suite is a new software package which can be used during coronary interventions. The software package includes two sub-packages, known as StentBoost and Cardiac Roadmapping.

The patient will undergo standard of care medical treatment for his or her cardiac condition. During the procedure, the physician may make angiograms for diagnosis and as reference for device navigation as part of the standard care. These angiograms will be automatically processed in PCI Suite and displayed on fluoroscopy for navigation support. In case a balloon catheter is inserted into the coronary arteries, the physician may take cine images as part of the standard care. These images can be automatically enhanced in PCI Suite. The primary objective of this prospective, mono-center, randomized clinical trial is to evaluate the amount of contrast medium used during percutaneous coronary intervention.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • hemodynamically relevant type A or B lesion

Exclusion

Exclusion Criteria:

  • hemodynamically relevant type C lesion

  • NSTEMI/STEMI

  • declined to participate

Study Design

Total Participants: 130
Study Start date:
April 24, 2017
Estimated Completion Date:
December 31, 2021

Connect with a study center

  • Division of Cardiology, Pulmonary Disease and Vascular Medicine

    Dusseldorf, 40225
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.